BACKGROUND: The m.3243A>G mutation can cause multisystem medical problems and can affect the autonomic nervous system. OBJECTIVE: To study the frequency and spectrum of autonomic symptoms associated with the m.3243A>G mitochondrial DNA point mutation. Design, Setting, and Patients We studied a cohort of 88 matrilineal relatives from 40 families, including 35 fully symptomatic patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS), 53 carrier relatives, and 16 controls using a questionnaire based on existing standard instruments for the evaluation of autonomic dysfunction. We compared the questionnaire with an expert evaluation. We compared data among the 3 groups using the Mantel-Haenszel chi(2) test to determine the statistical significance of differences between groups. RESULTS: Mutation carriers frequently had symptoms of autonomic dysfunction, specifically gastrointestinal and orthostatic intolerance. CONCLUSIONS: Carriers of the m.3243A>G mutation have frequent autonomic symptoms. The m.3243A>G mutation should be considered as an etiological factor in patients with autonomic dysfunction and a medical or family history suggestive of mitochondrial disease. Because some autonomic symptoms are treatable, early detection and proactive management may mitigate the burden of morbidity.
BACKGROUND: The m.3243A>G mutation can cause multisystem medical problems and can affect the autonomic nervous system. OBJECTIVE: To study the frequency and spectrum of autonomic symptoms associated with the m.3243A>G mitochondrial DNA point mutation. Design, Setting, and Patients We studied a cohort of 88 matrilineal relatives from 40 families, including 35 fully symptomatic patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS), 53 carrier relatives, and 16 controls using a questionnaire based on existing standard instruments for the evaluation of autonomic dysfunction. We compared the questionnaire with an expert evaluation. We compared data among the 3 groups using the Mantel-Haenszel chi(2) test to determine the statistical significance of differences between groups. RESULTS: Mutation carriers frequently had symptoms of autonomic dysfunction, specifically gastrointestinal and orthostatic intolerance. CONCLUSIONS: Carriers of the m.3243A>G mutation have frequent autonomic symptoms. The m.3243A>G mutation should be considered as an etiological factor in patients with autonomic dysfunction and a medical or family history suggestive of mitochondrial disease. Because some autonomic symptoms are treatable, early detection and proactive management may mitigate the burden of morbidity.
Authors: Neil Manwaring; Michael M Jones; Jie Jin Wang; Elena Rochtchina; Chris Howard; Paul Mitchell; Carolyn M Sue Journal: Mitochondrion Date: 2007-01-08 Impact factor: 4.160
Authors: M Hirano; G Silvestri; D M Blake; A Lombes; C Minetti; E Bonilla; A P Hays; R E Lovelace; I Butler; T E Bertorini Journal: Neurology Date: 1994-04 Impact factor: 9.910
Authors: M P van den Berg; R J Hassink; A E Tuinenburg; E F van Sonderen; J D Lefrandt; P J de Kam; I C van Gelder; A J Smit; R Sanderman; H J Crijns Journal: Eur Heart J Date: 2001-02 Impact factor: 29.983
Authors: Petra Kaufmann; Kristin Engelstad; Ying Wei; Romana Kulikova; Maryam Oskoui; Vanessa Battista; Dorcas Y Koenigsberger; Juan M Pascual; Mary Sano; Michio Hirano; Salvatore DiMauro; Dikoma C Shungu; Xiangling Mao; Darryl C De Vivo Journal: Arch Neurol Date: 2009-01
Authors: Lisa M Benrud-Larson; Melanie S Dewar; Paola Sandroni; Teresa A Rummans; Jennifer A Haythornthwaite; Phillip A Low Journal: Mayo Clin Proc Date: 2002-06 Impact factor: 7.616
Authors: Paul de Laat; Saskia Koene; Lambert P W J Vd Heuvel; Richard J T Rodenburg; Mirian C H Janssen; Jan A M Smeitink Journal: JIMD Rep Date: 2012-07-06
Authors: Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery Journal: Genet Med Date: 2017-07-27 Impact factor: 8.822
Authors: Matthew G D Bates; Jane H Newman; Djordje G Jakovljevic; Kieren G Hollingsworth; Charlotte L Alston; Pawel Zalewski; Jacek J Klawe; Andrew M Blamire; Guy A MacGowan; Bernard D Keavney; John P Bourke; Andrew Schaefer; Robert McFarland; Julia L Newton; Douglass M Turnbull; Robert W Taylor; Michael I Trenell; Gráinne S Gorman Journal: Int J Cardiol Date: 2013-06-03 Impact factor: 4.164
Authors: O V Poole; T Uchiyama; I Skorupinska; M Skorupinska; L Germain; D Kozyra; S Holmes; N James; E Bugiardini; C Woodward; R Quinlivan; A Emmanuel; M G Hanna; J N Panicker; R D S Pitceathly Journal: Eur J Neurol Date: 2019-04-30 Impact factor: 6.089